Integra LifeSciences Holdings Corporation
IART
$14.05
-$0.14-0.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.61% | -13.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.61% | -13.55% | |||
| Cost of Revenue | 11.29% | -5.26% | |||
| Gross Profit | 6.53% | -19.07% | |||
| SG&A Expenses | 7.21% | -7.73% | |||
| Depreciation & Amortization | 1.35% | -0.30% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.04% | -7.18% | |||
| Operating Income | 3.80% | -51.06% | |||
| Income Before Tax | -1,667.72% | -233.25% | |||
| Income Tax Expenses | -888.38% | -252.70% | |||
| Earnings from Continuing Operations | -1,813.86% | -230.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,813.86% | -230.14% | |||
| EBIT | 3.80% | -51.06% | |||
| EBITDA | 2.47% | -37.01% | |||
| EPS Basic | -1,808.01% | -230.08% | |||
| Normalized Basic EPS | -14.38% | -63.05% | |||
| EPS Diluted | -1,808.01% | -230.85% | |||
| Normalized Diluted EPS | -14.38% | -63.05% | |||
| Average Basic Shares Outstanding | 0.30% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||